LHC-CIDI-5 in Hong Kong

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 18, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

April 30, 2027

Conditions
Major Depressive Episode (MDE)Major Depressive Disorder (MDD)Persistent Depressive Disorder (PDD)Suicidal IdeationSuicidal PlanSuicidal AttemptSuicidal GestureNonsuicidal Self-InjuryManic EpisodeHypomanicBipolar I DisorderBipolar Sub DisorderBipolar II DisorderGeneralized Anxiety Disorder (GAD)Intermittent Explosive Disorder (IED)Panic AttackPanic DisorderObsessive-Compulsive Disorder (OCD)Posttraumatic Stress Disorder (PTSD)PCL-SC PTSDPCL-5 PTSDAlcohol Use Disorder (AUD)Substance Use Disorder (SUD)
Interventions
DIAGNOSTIC_TEST

CIDI-5

The World Health Organization Composite International Diagnostic Interview-5th (CIDI-5) is a standardized diagnostic tool used to assess the prevalence of mental and substance use disorders over varying time frames (30 days, 12 months, and lifetime) based on the diagnostic criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) and International Classification of Diseases 10th edition (ICD-10) . Trained interviewers will administrate selected modules from the Hong Kong version of the CIDI-5 in a computer-assisted personal interview to measure the outcomes.

DIAGNOSTIC_TEST

LHC-CIDI-5

The interviewer will start by asking the respondent's age and significant personal experiences, which is expected to take 15 minutes. Remembering and recording the experiences provide cognitive engagement and information which can further serve as memory cues for respondents in the following screening of CIDI-5. Subsequently, the respondents will proceed to the screening section for CIDI-5 and will refer to the completed calendar from the LHC section when they are asked to report lifetime experience or age-of-onset for mental disorders. Trained interviewers will conduct all interviews in a computer-assisted personal interview. To validate the diagnoses in the LHC-CIDI-5 group, clinical re-interviews for MDD, GAD, and PTSD will be conducted by a trained mental health professional with previous experience using DSM-5.

Trial Locations (1)

Unknown

RECRUITING

The University of Hong Kong, Hong Kong, SAR

All Listed Sponsors
lead

The University of Hong Kong

OTHER